A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boryung Pharmaceutical Co., Ltd
With
Seoul National University Hospital
Age
20–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
\<Renal impairment patient\>
age: 20-65 years
eGFR: \< 30ml/min/1.73m\^2
not on dialysis
body weight: greater than 55kg
written informed consent
\<Healthy volunteer\>
age: 20-65 years
body weight: greater than 55kg
written informed consent
You may not be if
AST, ALT \> 1.5 times of upper normal range
positive drug or alcohol screening
Clareo Health | A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
